Skip to content

Robert E. Hawkins

Brigham and Women's Hospital

1 paper in the Anchorcite directory, published in 2018, cited 4,757 times in total.

Research topics

Frequent co-authors

Papers

  1. Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell CarcinomaNew England Journal of Medicine · 2018 · 4,757 citations

    BACKGROUND: Nivolumab plus ipilimumab produced objective responses in patients with advanced renal-cell carcinoma in a pilot study. This phase 3 trial compared nivolumab plus ipilimumab with sunitinib for previously untreated clear-cell advanced renal-cell carcinoma. METHODS: We randomly assigned adults in…

Metadata from OpenAlex (CC0).